Felbamate 600 MG Oral Tablet [Felbatol] — RxCUI 209027
RxNorm drug concept · Semantic branded drug
RxCUI 209027
Semantic branded drug · SBD
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI209027
Official nameFelbamate 600 MG Oral Tablet [Felbatol]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asFelbatol 600 MG Oral Tablet; FELT 600 MG Oral Tablet [Felbatol]
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)1,679 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Felbamate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Felbamate is reserved for people whose epilepsy is severe and hasn't responded well enough to safer options. It's not a first choice — your doctor is recommending it because the be...
- Why is my doctor prescribing felbamate instead of a different seizure medication?
- There are two major ones. First, felbamate can cause aplastic anemia — a serious condition where your bone marrow stops making enough blood cells. Watch for unusual bruising, bleed...
- What are the biggest dangers I need to watch out for while taking felbamate?
🕸️ Concept Web — How Felbamate 600 MG Oral Tablet [Felbatol] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Felbamate 600 MG Oral Tablet [Felbatol]
RxCUI 209027 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Felbamate
24812IN
-
Felbamate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Felbatol
224900BN
-
Felbatol
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Felbamate Oral Tablet
372145SCDF -
Felbamate Oral Product
1163810SCDG -
Felbamate Pill
1163811SCDG -
Felbamate Oral Tablet [Felbatol]
369165SBDF -
Felbatol Oral Product
1176002SBDG -
Felbatol Pill
1176003SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Felbamate Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Felbamate 600 MG Oral Tablet
198359SCD -
Felbamate 600 MG
315924SCDC -
Felbamate 600 MG [Felbatol]
569662SBDC
-
Felbamate 600 MG Oral Tablet
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Felbamate 600 MG Oral Tablet
SCD · 198359 -
Felbamate 600 MG
SCDC · 315924 -
Felbamate Oral Tablet
SCDF · 372145 -
Felbamate Oral Product
SCDG · 1163810 -
Felbamate Pill
SCDG · 1163811
Brand-Name Concepts
-
Felbamate 600 MG [Felbatol]
SBDC · 569662 -
Felbamate Oral Tablet [Felbatol]
SBDF · 369165 -
Felbatol Oral Product
SBDG · 1176002 -
Felbatol Pill
SBDG · 1176003 -
Felbatol
BN · 224900
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 209027 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00037-0430-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0037-0430-01) | Felbatol | Viatris Specialty LLC | 1993-07-29 |
| 00037-0431-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0037-0431-01) | Felbatol | Viatris Specialty LLC | 1993-07-29 |
Observed labelers:
Viatris Specialty LLC (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.